{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:11Z","timestamp":1790276351702,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20262BAC240360"],"award-info":[{"award-number":["20262BAC240360"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC200504"],"award-info":[{"award-number":["20252BAC200504"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117409","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:37:32Z","timestamp":1789184252000},"page":"117409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of PARP1-mediated parthanatos by rucaparib phosphate alleviates sepsis-induced acute lung injury"],"prefix":"10.1016","volume":"189","author":[{"given":"Huaigang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117409_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2026.117409_bb0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0140-6736(07)60604-7","article-title":"Acute lung injury and the acute respiratory distress syndrome: a clinical review","volume":"369","author":"Wheeler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117409_bb0015","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117409_bb0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/17435390.2021.1936254","article-title":"8-Hydroxy-2\u2032-deoxyguanosine (8-OHdG) as a biomarker of oxidative DNA damage induced by occupational exposure to nanomaterials: a systematic review","volume":"15","author":"Omari Shekaftik","year":"2021","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.intimp.2026.117409_bb0025","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.3390\/ijms21239317","article-title":"Airway redox homeostasis and inflammation gone awry: from molecular pathogenesis to emerging therapeutics in respiratory pathology","volume":"21","author":"Checa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117409_bb0030","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos)","volume":"4","author":"Wang","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2026.117409_bb0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/STROKEAHA.107.511857","article-title":"Advances in neuronal cell death 2007","volume":"39","author":"Harraz","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2026.117409_bb0040","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/nar\/gkz120","article-title":"Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins","volume":"47","author":"Alemasova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.2012.64","article-title":"Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity","volume":"82","author":"Kim","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2026.117409_bb0050","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s10753-025-02247-y","article-title":"PARP1 exacerbates prostatitis by promoting M1 macrophages polarization through NF-\u03baB pathway","volume":"48","author":"Jin","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2026.117409_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","author":"Vir\u00e1g","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2026.117409_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-024-01880-0","article-title":"Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma","volume":"10","author":"Fei","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117409_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jare.2024.04.031","article-title":"Exploring the role of parthanatos in CNS injury: molecular insights and therapeutic approaches","volume":"70","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0070","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/3297","article-title":"Parthanatos, a messenger of death","volume":"14","author":"David","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.intimp.2026.117409_bb0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.117409_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233789","article-title":"Efficacy of clinically used PARP inhibitors in a murine model of acute lung injury","volume":"11","author":"Martins","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117409_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.expneurol.2009.03.020","article-title":"Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos","volume":"218","author":"Wang","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.117409_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101239","article-title":"Programmed necrotic cell death of macrophages: focus on pyroptosis, necroptosis, and parthanatos","volume":"26","author":"Robinson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.117409_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2741\/4302","article-title":"Isoflurane attenuates LPS-induced acute lung injury by targeting miR-155-HIF1-alpha","volume":"20","author":"Hu","year":"2015","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.intimp.2026.117409_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104263","volume":"145","author":"Ahmad","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11010-014-2271-4","article-title":"PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice","volume":"400","author":"Kapoor","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.117409_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40265-017-0716-2","article-title":"Rucaparib: first global approval","volume":"77","author":"Syed","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2026.117409_bb0115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa2214676","article-title":"Rucaparib or physician\u2019s choice in metastatic prostate Cancer","volume":"388","author":"Fizazi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117409_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918778483","article-title":"Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy","volume":"10","author":"Dal Molin","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.intimp.2026.117409_bb0125","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40262-022-01157-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of Rucaparib","volume":"61","author":"Liao","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.intimp.2026.117409_bb0130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","article-title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Coleman","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117409_bb0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00003246-200205000-00019","article-title":"Novel phenanthridinone inhibitors of poly (adenosine 5\u2032-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents","volume":"30","author":"Jagtap","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2026.117409_bb0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2018.11.034","article-title":"LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis","volume":"131","author":"Regdon","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.117409_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/PL00000234","article-title":"Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase","volume":"50","author":"Mabley","year":"2001","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0150","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1073\/pnas.170226797","article-title":"Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase","volume":"97","author":"Liaudet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.117409_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bph.13735","article-title":"The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury","volume":"175","author":"Ahmad","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117409_bb0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bph.13748","article-title":"Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases","volume":"175","author":"Berger","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117409_bb0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41420-024-02114-z","article-title":"Parthanatos initiated by ROS-induced DNA damage is involved in intestinal epithelial injury during necrotizing enterocolitis","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117409_bb0170","article-title":"Intestine-decipher engineered capsules protect against Sepsis-induced intestinal injury via broad-spectrum anti-inflammation and Parthanatos inhibition","volume":"12","author":"Yan","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.intimp.2026.117409_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.119202","article-title":"Lysosomal impairment-mediated autophagy dysfunction responsible for the vascular endothelial apoptosis caused by silica nanoparticle via ROS\/PARP1\/AIF signaling pathway","volume":"304","author":"Abulikemu","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.intimp.2026.117409_bb0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1541-7786.MCR-21-0652","article-title":"cAMP-mediated autophagy promotes cell survival via ROS-induced activation of PARP1: implications for treatment of acute lymphoblastic leukemia","volume":"20","author":"Richartz","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114630","article-title":"PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration","volume":"252","author":"Zhang","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2026.117409_bb0190","article-title":"Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117409_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712556","article-title":"The critical role of PARPs in regulating innate immune responses","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117409_bb0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0006-2952(03)00077-7","article-title":"Decrease of the inflammatory response and induction of the Akt\/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock","volume":"65","author":"Veres","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117409_bb0205","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/s41401-023-01109-3","article-title":"Activated SIRT1 contributes to DPT-induced glioma cell parthanatos by upregulation of NOX2 and NAT10","volume":"44","author":"Liang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.117409_bb0210","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1007\/s12035-016-9926-y","article-title":"JNK activation contributes to oxidative stress-induced parthanatos in glioma cells via increase of intracellular ROS production","volume":"54","author":"Zheng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117409_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115011","article-title":"Dihydrocapsaicin enhances tumor necrosis factor-\u03b1-induced apoptosis and G1 cell cycle arrest in human cervical cancer cells through TAK1-mediated NF-\u03baB and EGFR pathways","volume":"26","author":"Boonyarat","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117409_bb0220","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.neuron.2025.04.002","article-title":"NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis","volume":"113","author":"Zhan","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117409_bb0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12931-024-02678-5","article-title":"Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)","volume":"25","author":"Huang","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2026.117409_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1605797","article-title":"Alveolar epithelial cells in bacterial sepsis-associated acute lung injury: mechanisms and therapeutic strategies","volume":"16","author":"Jia","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117409_bb0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clim.2007.08.017","article-title":"Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction","volume":"126","author":"Li","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2026.117409_bb0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41419-022-04967-7","article-title":"PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells","volume":"13","author":"Qin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117409_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41586-026-10404-y","article-title":"Two decades of PARP inhibitor synthetic lethality in cancer","volume":"653","author":"Lord","year":"2026","journal-title":"Nature"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:03:35Z","timestamp":1790273015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926012567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"alternative-id":["S1567576926012567"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117409","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of PARP1-mediated parthanatos by rucaparib phosphate alleviates sepsis-induced acute lung injury","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117409"}}